Gene transfections with p53 and p21 inhibit cell proliferation, collagen type I, leukemia inhibitory factor, and tumor necrosis factor-α expression in leiomyoma cells

Fertility and Sterility

Volumn 81, Issue 6, 2004, Pages 1665-1670

  Hsieh, Yao Yuan ^a,b   Chang, Chi Chen ^b   Hsu, Chih Wei ^a   Lin, Chich Sheng ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

collagen type I; leukemia inhibitory factor; p21; p53; tumor necrosis factor

Indexed keywords

COLLAGEN TYPE 1; COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LEUKEMIA INHIBITORY FACTOR; PROTEIN P21; PROTEIN P53; RNA; TETRAZOLIUM BLUE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOASSAY; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA VECTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; LEIOMYOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR CELL CULTURE;

CELL DIVISION; COLLAGEN TYPE I; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENES, P53; HUMANS; INTERLEUKIN-6; LEIOMYOMA; LEUKEMIA INHIBITORY FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UTERINE NEOPLASMS;

EID: 2942552551     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.02.062     Document Type: Article

References (59)

1. Cramer D.W. Epidemiology of myomas. Semin Reprod Endocrinol. 10:1992;320-324
2. Andersen J., Barbieri R.L. Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Investig. 2:1995;663-672
3. Hong T., Shimada Y., Uchida S., Itami A., Li Z., Ding Y., et al. Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int J Mol Med. 8:2001;141-148
4. Miyajima K., Tamiya S., Oda Y., Adachi T., Konomoto T., Toyoshiba H., et al. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction. Cancer Lett. 164:2001;177-188
5. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704
6. el-Deiry W.S., Tokino T., Waldman T., Oliner J.D., Velculescu V.E., Burrell M., et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55:1995;2910-2919
7. Tsan M.F., White J.E., Shepard B. Lung-specific direct in vivo gene transfer with recombinant plasmid DNA. Am J Physiol. 268:1995;L1052-L1056
8. Zou Y., Zong G., Ling Y.H., Perez-Soler R. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Cancer Gene Ther. 7:2000;683-696
9. Schmid R.M., Weidenbach H., Yamagushi H., Luhrs H., Liptay S., Adler G. Direct gene transfer into the rat pancreas using DNA-liposomes. Eur J Clin Invest. 28:1998;220-226
10. Charnock-Jones D.S., Sharkey A.M., Jaggers D.C., Yoo H.J., Heap R.B., Smith S.K. In-vivo gene transfer to the uterine endometrium. Hum Reprod. 12:1997;17-20
11. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468
12. Song Y.K., Liu F., Chu S., Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther. 8:1997;1585-1594
13. Schmid R.M., Weidenbach H., Yamagushi H., Luhrs H., Liptay S., Adler G. Direct gene transfer into the rat pancreas using DNA-liposomes. Eur J Clin Invest. 28:1998;220-226
14. Niu H., Simari R.D., Zimmermann E.M., Christman G.M. Nonviral vector-mediated thymidine kinase gene transfer and ganciclovir treatment in leiomyoma cells. Obstet Gynecol. 91:1998;735-740
15. Milas M., Yu D., Lang A., Ge T., Feig B., El-Naggar A.K., et al. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity. Cancer Gene Ther. 7:2000;422-429
16. Kobayashi Y., Nikaido T., Zhai Y.L., Iinuma M., Shiozawa T., Shirota M., et al. In-vitro model of uterine leiomyomas formation of ball-like aggregates. Hum Reprod. 11:1996;1724-1730
17. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 161:1987;156-159
18. Lin C.S., Wu Y.C., Sun Y.L., Huang M.C. Postnatal expression of growth/differentiation factor-8 (GDF-8) gene in European and Asian pigs. Asian-Australia J Anim Sci. 9:2002;1244-1249
19. Spencer W.E., Christensen M.J. Multiplex relative RT-PCR method for verification of differential gene expression. BioTechniques. 27:1999;1044-1052
20. Moolten F.L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes paradigm for a prospective cancer control strategy. Cancer Res. 46:1986;5276-5281
21. Culver K.W., Ram Z., Wallbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552
22. Barnes M.N., Deshane J.S., Rosenfeld M., Siegal G.P., Curiel D.T., Alvarez R.D. Gene therapy and ovarian cancer a review. Obstet Gynecol. 89:1997;145-155
23. Freeman S.M., Abboud C.N., Whartenby K.A., Packman C.H., Koeplin D.S., Moolten F.L., et al. The "bystander effect:" tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53:1993;5274-5283
24. Rosenthal A.N., Ryan A., Al-Jehani R.M., Storey A., Harwood C.A., Jacobs I.J. P53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet. 352:1998;871-872
25. Kupryjanczyk J., Bell D.A., Yandell D.W., Scully R.E., Thor A.D. p53 expression in ovarian borderline tumors and stage I carcinomas. Am J Clin Pathol. 102:1994;671-676
26. Esrig D., Elmajian D., Groshen S., Freeman J.A., Stein J.P., Chen S.C., et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Eng J Med. 331:1994;1259-1264
27. Steiner M.S., Zhang X., Wang Y., Lu Y. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Res. 60:2000;4419-4425
28. Wang N.M., Tsai C.H., Yeh K.T., Chen S.J., Chang J.G. P53 codon 72 arg polymorphism is not a risk factor for carcinogenesis in the Chinese. Int J Mol Med. 4:1999;249-252
29. Takeda A., Shimada H., Nakajima K., Suzuki T., Hori S., Hayashi H., et al. Impact of circulating p53 autoantibody monitoring after endoscopic resection in mucosal gastric cancer. Endoscopy. 32:2000;740-741
30. Nutt C.L., Noble M., Chambers A.F., Cairncross J.G. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res. 60:2000;4812-4818
31. Chang K.W., Lin S.C., Mangold K.A., Jean M.S., Yuan T.C., Lin S.N., et al. Alterations of adenomatous polyposis Coli (APC) gene in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 29:2000;223-226
32. Crook T., Nicholls J.M., Brooks L., O'Nions J., Allday M.J. High level expression of deltaN-p63 a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene. 19:2000;3439-3444
33. Miyazaki T., Kato H., Shitara Y., Yoshikawa M., Tajima K., Masuda N., et al. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer. 89:2000;955-962
34. Pich A., Margaria E., Chiusa L. Oncogenes and male breast carcinoma c-erbB-2 and p53 coexpression predicts a poor survival. J Clin Oncol. 18:2000;2948-2956
35. Boley S.E., Anderson E.E., French J.E., Donehower L.A., Walker D.B., Recio L. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice evidence of chromosomal recombination. Cancer Res. 60:2000;2831-2835
36. Chang C.C., Hsieh Y.Y., Tsai F.J., Tsai C.H., Tsai H.D., Lin C.C. The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril. 77:2002;43-45
37. Zhang L., Yu D., Hu M., Xiong S., Lang A., Ellis L.M., et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res. 60:2000;3655-3661
38. Finlay C.A., Hinds P.W., Levine A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 57:1989;1083-1093
39. Li X., Jiao S., Mi R. Clinical significance of p21H-ras expression and H-ras codon 12 mutation in squamous intraepithelial lesion (SIL) and carcinoma of uterine cervix. Chung Hua Chung Liu Tsa Chih. 19:1997;306-308
40. Levesque M.A., Katsaros D., Massobrio M., Genta F., Yu H., Richiardi G., et al. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Clin Cancer Res. 6:2000;3260-3270
41. Jahnson S., Karlsson M.G. Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma. Cancer. 89:2000;619-629
42. Cheng L., Lloyd R.V., Weaver A.L., Pisansky T.M., Cheville J.C., Ramnani D.M., et al. The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res. 6:2000;1896-1899
43. Hsu S.L., Chen M.C., Chou Y.H., Hwang G.Y., Yin S.C. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Exp Cell Res. 248:1999;87-96
44. Pasz-Walczak G., Kordek R. Comparative evaluation of the expression of cell cycle regulating proteins cyclin D1, p53 and p21 (WAF1) in colorectal cancer. Pol J Pathol. 51:2000;63-69
45. Schneider J., Presek P., Braun A., Loffler S., Woitowitz H.J. Serum ras (p21) as a marker for occupationally derived lung cancer? Clin Chem Lab Med. 38:2000;301-305
46. Koopmann J., Maintz D., Schild S., Schramm J., Louis D.N., Wiestler O.D., et al. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumors. Br J Cancer. 72:1995;1230-1233
47. Harada K., Ogden G.R. An overview of the cell cycle arrest protein, p21 (WAF1). Oral Oncol. 36:2000;3-7
48. Lin C.S., Kuo H.H., Chen J.Y., Yang C.S., Wang W.B. Epstein-Barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally. J Mol Biol. 303:2000;7-23
49. Woodward T.A., Klingler P.D., Genko P.V., Wolfe J.T. Barrett's esophagus, apoptosis and cell cycle regulation correlation of p53 with Bax, Bcl-2 and p21 protein expression. Anticancer Res. 20:2000;2427-2432
50. Chen X., Danes C., Lowe M., Herliczek T.W., Keyomarsi K. Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells. J Natl Cancer Inst. 92:2000;1403-1413
51. Kanavaros P., Stefanaki K., Vlachonikolis J., Eliopoulos G., Kakolyris S., Rontogianni D., et al. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas. Histol Histopathol. 15:2000;445-453
52. Hsieh Y.Y., Tsai F.J., Chang C.C., Chen W.C., Tsai C.H., Tsai H.D., et al. p21 gene codon 31 arginine/serine polymorphism non-association with endometriosis. J Clin Lab Anal. 15:2001;184-187
53. Palazzo J.P., Mercer W.E., Kovatich A.J., McHugh M. Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues. Hum Pathol. 28:1997;60-66
54. Lee T.H., Chuang L.Y., Hung W.C. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells. Oncogene. 18:1999;4269-4274
55. Tsai H.D., Chang C.C., Hsieh Y.Y., Lo H.Y., Hsu L.W., Chang S.C. Recombinant human leukemia inhibitory factor enhances the development of preimplantation mouse embryo in vitro. Fertil Steril. 71:1999;722-725
56. Kamohara H., Sakamoto K., Ishiko T., Masuda Y., Abe T., Ogawa M. Leukemia inhibitory factor induces apoptosis and proliferation of human carcinoma cells through different oncogene pathways. Int J Cancer. 72:1997;687-695
57. Calhaz-Jorge C., Costa A.P., Barata M., Santos M.C., Melo A., Palma-Carlos M.L. Tumour necrosis factor alpha concentrations in the peritoneal fluid of infertile women with minimal or mild endometriosis are lower in patients with red lesions only than in patients without red lesions. Hum Reprod. 15:2000;1256-1260
58. Hyde S.C., Gill D.R., Higgins C.F., Trezise A.E., MacVinish L.J., Cuthbert A.W., et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature. 362:1993;250-255
59. Hsieh Y.Y., Lin C.S., Sun Y.L., Chang C.C., Tsai H.D., Wu J.C. In vivo gene transfer of leukemia inhibitory factor (LIF) into mouse endometrium. J Assist Reprod Genet. 19:2002;79-83